The epidermal growth factor receptor (EGFR), a membrane-bound receptor tyrosine kinase (RTK), is mostly deregulated by somatic mutations and amplification and is overexpressed in different cancers such as non-small cell lung cancer, esophageal cancer, and PM [38,39]. Here, EGFR is linked to cancer.